The Journal of Immunology, 2005, 174: 1073-1080.
Copyright © 2005 by The American Association of Immunologists
A2A Adenosine Receptor Induction Inhibits IFN-
Production in Murine CD4+ T Cells1
Courtney M. Lappas2,*,
Jayson M. Rieger
and
Joel Linden
* Departments of Pharmacology and
Medicine, University of Virginia, Charlottesville, VA 22908; and
Adenosine Therapeutics, LLC, Charlottesville, VA 22911
Incubation of purified C57BL/6 murine CD4+ T lymphocytes with anti-CD3 mAb serves as a model of TCR-mediated activation and results in increased IFN-
production and cell surface expression of CD25 and CD69. We demonstrate here that signaling through the TCR causes a rapid (4-h) 5-fold increase in A2A adenosine receptor (AR) mRNA, which is correlated with a significant increase in the efficacy of A2AAR-mediated cAMP accumulation in these cells. A2AAR activation reduces TCR-mediated production of IFN- by 98% with a potency order of 4-{3-[6-amino-9-(5-ethylcarbamoyl-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-2-yl]prop-2-ynyl}cyclohexanecarboxylic acid methyl ester (ATL146e; EC50 = 0.19 ± 0.03 nM) > 4-{3-[6-amino-9-(5-cyclopropyl-carbamoyl-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-2-yl]prop-2-ynyl}piperidine-1-carboxylic acid methyl ester (ATL313; 0.43 ± 0.06 nM) > 5'-N-ethylcarboxamidoadenosine (3.5 ± 0.77 nM) > 2-[4-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamidoadenosine (CGS21680 7.2 ± 1.4 nM) >> N6-cyclohexyladenosine (110 ± 33 nM) > 2-chloro-N6-(3-iodobenzyl)-5'-N-methylcarboxamide (390 ± 160 nM), similar to the potency order to compete for radioligand binding to the recombinant murine A2AAR but not the A3AR. The selective A2AAR antagonist, 4-(2-[7-amino-2-[2-furyl][1,2,4]triazolo[2,3-a][1,3,5]triazin-5-yl-amino]ethyl)phenol (ZM241385), inhibits the effect of ATL146e with a pA2 of 0.34 nM and also inhibits the effects of N6-cyclohexyl-adenosine and 2-chloro-N6-(3-iodobenzyl)-5'-N-methylcarboxamide. In CD4+ T cells derived from A2AAR–/– and A2AAR+/– mice, the IFN- release response to ATL146e is reduced by 100 and 50%, respectively, indicative of a gene dose effect. The response of T cells to the phosphodiesterase inhibitor, 4-(3'-cyclopentyloxy-4'-methoxyphenyl)-2-pyrrolidone (rolipram), is not affected by A2AAR deletion. We conclude that the rapid induction of the A2AAR mRNA in T cells provides a mechanism for limiting T cell activation and secondary macrophage activation in inflamed tissues.
This article has been cited by other articles:
|
|
|
|
 
D. van der Hoeven, T. C. Wan, and J. A. Auchampach
Activation of the A3 Adenosine Receptor Suppresses Superoxide Production and Chemotaxis of Mouse Bone Marrow Neutrophils
Mol. Pharmacol.,
September 1, 2008;
74(3):
685 - 696.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Huang, Z. Lei, G.-M. Zhang, D. Li, C. Song, B. Li, Y. Liu, Y. Yuan, J. Unkeless, H. Xiong, et al.
SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment
Blood,
August 15, 2008;
112(4):
1269 - 1279.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Huang, D. J. Moore, R. J. Ketchum, C. S. Nunemaker, B. Kovatchev, A. L. McCall, and K. L. Brayman
Resolving the Conundrum of Islet Transplantation by Linking Metabolic Dysregulation, Inflammation, and Immune Regulation
Endocr. Rev.,
August 1, 2008;
29(5):
603 - 630.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. M. Tomayko, S. M. Anderson, C. E. Brayton, S. Sadanand, N. C. Steinel, T. W. Behrens, and M. J. Shlomchik
Systematic Comparison of Gene Expression between Murine Memory and Naive B Cells Demonstrates That Memory B Cells Have Unique Signaling Capabilities
J. Immunol.,
July 1, 2008;
181(1):
27 - 38.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Cassani, M. Mirolo, F. Cattaneo, U. Benninghoff, M. Hershfield, F. Carlucci, A. Tabucchi, C. Bordignon, M. G. Roncarolo, and A. Aiuti
Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients
Blood,
April 15, 2008;
111(8):
4209 - 4219.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Gazoni, V. E. Laubach, D. P. Mulloy, A. Bellizzi, E. B. Unger, J. Linden, P. I. Ellman, T. C. Lisle, and I. L. Kron
Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion
J. Thorac. Cardiovasc. Surg.,
January 1, 2008;
135(1):
156 - 165.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. E. Zarek, C.-T. Huang, E. R. Lutz, J. Kowalski, M. R. Horton, J. Linden, C. G. Drake, and J. D. Powell
A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells
Blood,
January 1, 2008;
111(1):
251 - 259.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Ohta, D. Lukashev, E. K. Jackson, B. B. Fredholm, and M. Sitkovsky
1,3,7-Trimethylxanthine (Caffeine) May Exacerbate Acute Inflammatory Liver Injury by Weakening the Physiological Immunosuppressive Mechanism
J. Immunol.,
December 1, 2007;
179(11):
7431 - 7438.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Csoka, Z. H. Nemeth, L. Virag, P. Gergely, S. J. Leibovich, P. Pacher, C.-X. Sun, M. R. Blackburn, E. S. Vizi, E. A. Deitch, et al.
A2A adenosine receptors and C/EBP{beta} are crucially required for IL-10 production by macrophages exposed to Escherichia coli
Blood,
October 1, 2007;
110(7):
2685 - 2695.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. C. Caldwell, J. Tschoep, and A. B. Lentsch
Lymphocyte function during hepatic ischemia/reperfusion injury
J. Leukoc. Biol.,
September 1, 2007;
82(3):
457 - 464.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. H. Nemeth, D. Bleich, B. Csoka, P. Pacher, J. G. Mabley, L. Himer, E. S. Vizi, E. A. Deitch, C. Szabo, B. N. Cronstein, et al.
Adenosine receptor activation ameliorates type 1 diabetes
FASEB J,
August 1, 2007;
21(10):
2379 - 2388.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Reutershan, R. E. Cagnina, D. Chang, J. Linden, and K. Ley
Therapeutic Anti-Inflammatory Effects of Myeloid Cell Adenosine Receptor A2a Stimulation in Lipopolysaccharide-Induced Lung Injury
J. Immunol.,
July 15, 2007;
179(2):
1254 - 1263.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Li, L. Huang, S.-s. J. Sung, P. I. Lobo, M. G. Brown, R. K. Gregg, V. H. Engelhard, and M. D. Okusa
NKT Cell Activation Mediates Neutrophil IFN-{gamma} Production and Renal Ischemia-Reperfusion Injury
J. Immunol.,
May 1, 2007;
178(9):
5899 - 5911.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. P. Sevigny, L. Li, A. S. Awad, L. Huang, M. McDuffie, J. Linden, P. I. Lobo, and M. D. Okusa
Activation of Adenosine 2A Receptors Attenuates Allograft Rejection and Alloantigen Recognition
J. Immunol.,
April 1, 2007;
178(7):
4240 - 4249.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Lappas, Y.-J. Day, M. A. Marshall, V. H. Engelhard, and J. Linden
Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation
J. Exp. Med.,
November 27, 2006;
203(12):
2639 - 2648.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Kobie, P. R. Shah, L. Yang, J. A. Rebhahn, D. J. Fowell, and T. R. Mosmann
T Regulatory and Primed Uncommitted CD4 T Cells Express CD73, Which Suppresses Effector CD4 T Cells by Converting 5'-Adenosine Monophosphate to Adenosine
J. Immunol.,
November 15, 2006;
177(10):
6780 - 6786.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Yang, Y.-J. Day, M.-C. Toufektsian, Y. Xu, S. I. Ramos, M. A. Marshall, B. A. French, and J. Linden
Myocardial Infarct-Sparing Effect of Adenosine A2A Receptor Activation Is due to Its Action on CD4+ T Lymphocytes
Circulation,
November 7, 2006;
114(19):
2056 - 2064.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Lukashev, B. Klebanov, H. Kojima, A. Grinberg, A. Ohta, L. Berenfeld, R. H. Wenger, A. Ohta, and M. Sitkovsky
Cutting Edge: Hypoxia-Inducible Factor 1{alpha} and Its Activation-Inducible Short Isoform I.1 Negatively Regulate Functions of CD4+ and CD8+ T Lymphocytes
J. Immunol.,
October 15, 2006;
177(8):
4962 - 4965.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Naganuma, E. B. Wiznerowicz, C. M. Lappas, J. Linden, M. T. Worthington, and P. B. Ernst
Cutting Edge: Critical Role for A2A Adenosine Receptors in the T Cell-Mediated Regulation of Colitis.
J. Immunol.,
September 1, 2006;
177(5):
2765 - 2769.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Linden
Adenosine metabolism and cancer. Focus on "Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatases and reducing ERK1/2 activity via a novel pathway"
Am J Physiol Cell Physiol,
September 1, 2006;
291(3):
C405 - C406.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Linden
Ups and downs of adenosine
Blood,
September 1, 2006;
108(5):
1430 - 1430.
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. C. Cavalcante, M. V. Castro, A. R. F. Barreto, G. W. Sullivan, M. Vale, P. R. C. Almeida, J. Linden, J. M. Rieger, F. Q. Cunha, R. L. Guerrant, et al.
Effect of Novel A2A Adenosine Receptor Agonist ATL 313 on Clostridium difficile Toxin A-Induced Murine Ileal Enteritis.
Infect. Immun.,
May 1, 2006;
74(5):
2606 - 2612.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. H. Nemeth, B. Csoka, J. Wilmanski, D. Xu, Q. Lu, C. Ledent, E. A. Deitch, P. Pacher, Z. Spolarics, and G. Hasko
Adenosine A2A Receptor Inactivation Increases Survival in Polymicrobial Sepsis
J. Immunol.,
May 1, 2006;
176(9):
5616 - 5626.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Fortin, D. Harbour, M. Fernandes, P. Borgeat, and S. Bourgoin
Differential expression of adenosine receptors in human neutrophils: up-regulation by specific Th1 cytokines and lipopolysaccharide
J. Leukoc. Biol.,
March 1, 2006;
79(3):
574 - 585.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-J. Day, L. Huang, H. Ye, L. Li, J. Linden, and M. D. Okusa
Renal Ischemia-Reperfusion Injury and Adenosine 2A Receptor-Mediated Tissue Protection: The Role of CD4+ T Cells and IFN-{gamma}.
J. Immunol.,
March 1, 2006;
176(5):
3108 - 3114.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Linden
Adenosine in Tissue Protection and Tissue Regeneration
Mol. Pharmacol.,
May 1, 2005;
67(5):
1385 - 1387.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-J. Day, Y. Li, J. M. Rieger, S. I. Ramos, M. D. Okusa, and J. Linden
A2A Adenosine Receptors on Bone Marrow-Derived Cells Protect Liver from Ischemia-Reperfusion Injury
J. Immunol.,
April 15, 2005;
174(8):
5040 - 5046.
[Abstract]
[Full Text]
[PDF]
|
|
|
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
